Business Description
Hoth Therapeutics Inc
NAICS : 325411
SIC : 2833
ISIN : US44148G2049
Share Class Description:
HOTH: Ordinary SharesDescription
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 235.97 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.5 | |||||
| 3-Year EPS without NRI Growth Rate | 46.2 | |||||
| 3-Year FCF Growth Rate | 42 | |||||
| 3-Year Book Growth Rate | -38.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 35.94 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.41 | |||||
| 9-Day RSI | 39.01 | |||||
| 14-Day RSI | 43.25 | |||||
| 3-1 Month Momentum % | -20.62 | |||||
| 6-1 Month Momentum % | -9.19 | |||||
| 12-1 Month Momentum % | -30.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.17 | |||||
| Quick Ratio | 10.17 | |||||
| Cash Ratio | 9.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -100.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -85.33 | |||||
| ROA % | -77.49 | |||||
| ROIC % | -5544.92 | |||||
| 3-Year ROIIC % | 115.04 | |||||
| ROC (Joel Greenblatt) % | -7346.34 | |||||
| ROCE % | -85.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.78 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| EV-to-EBIT | 0.28 | |||||
| EV-to-EBITDA | 0.28 | |||||
| EV-to-FCF | 0.27 | |||||
| Price-to-Net-Current-Asset-Value | 0.75 | |||||
| Price-to-Net-Cash | 0.78 | |||||
| Earnings Yield (Greenblatt) % | 357.14 | |||||
| FCF Yield % | -137.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HOTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hoth Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.32 | ||
| Beta | 0.27 | ||
| 3-Year Sharpe Ratio | -0.64 | ||
| 3-Year Sortino Ratio | -1.03 | ||
| Volatility % | 63.78 | ||
| 14-Day RSI | 43.25 | ||
| 14-Day ATR ($) | 0.056871 | ||
| 20-Day SMA ($) | 0.831565 | ||
| 12-1 Month Momentum % | -30.7 | ||
| 52-Week Range ($) | 0.58 - 1.73 | ||
| Shares Outstanding (Mil) | 6.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hoth Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hoth Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hoth Therapeutics Inc Frequently Asked Questions
What is Hoth Therapeutics Inc(HOTH)'s stock price today?
The current price of HOTH is $0.81. The 52 week high of HOTH is $1.73 and 52 week low is $0.58.
When is next earnings date of Hoth Therapeutics Inc(HOTH)?
The next earnings date of Hoth Therapeutics Inc(HOTH) is 2025-02-12 Est..
Does Hoth Therapeutics Inc(HOTH) pay dividends? If so, how much?
Hoth Therapeutics Inc(HOTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers